NON-INVASIVE TESTS FOR CLINICALLY SIGNIFICANT PORTAL HYPERTENSION AFTER HCV-CURE – INDIVIDUAL PATIENT DATA META-ANALYSIS AND VALIDATION

Georg Semmler  ¹     Sabela Lens  ²     Elias Laurin Meyer  ²     Anna Baiges  ²     Edilmar Alvarado  ³     Elba Llop  ³     Luis Téllez  ⁴     Philipp Schwabl  ⁴     Ezequiel Mauro  ⁵     Laia Escude  ⁵     Christina Diez  ⁶     LUIS IBÁÑEZ SAMANIEGO  ⁶     Angela Puente  ⁷     Jose Ignacio Fortea Ormaechea  ⁷     Marta Abadia  ⁸     Alberto Zanetto  ⁹     Jidong Jia  ¹⁰     Hitoshi Yoshiji  ¹¹     Sven Francque  ¹²     Emmanuel Tsochatzis  ¹³     Francesco Paolo Russo  ¹³     Gonzalo Crespo  ¹³     Xavier Forns  ¹³     Rafael Banares  ¹⁴     Cándido Villanueva  ¹⁴     Virginia Hernández-Gea  ¹⁴     Thomas Reiberger  ¹⁴     Jaime Bosch  ¹⁴     Juan Carlos Garcia Pagan  ¹⁴     Mattias Mandorfer  ^14    
1 Medical University of Vienna, Vienna, Austria
² Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
³ Centro de Investigación Biomédica En Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain
⁴ Hospital Universitario Ramón y Cajal, IRYCIS, University of Alcalá, Madrid, Spain
⁵ Hospital Italiano, Buenos Aires, Argentina
⁶ Hospital General Universitario Gregorio Marañón, Madrid, Spain
⁷ Hospital Universitario Marqués de Valdecilla, Santander, Spain
⁸ Hospital Universitario La Paz, Madrid, Spain
⁹ Padua University Hospital, Padua, Italy
¹⁰ Beijing Friendship Hospital, Capital Medial University, Beijing, China
¹¹ Nara Medical University, Naja, Japan
¹² Antwerp University Hospital, Antwerp, Antwerp, Belgium
¹³ Royal Free Hospital and UCL, London, United Kingdom
¹⁴ Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain

Topic
Disease Mechanisms, Hepatobiliary, IBD, Nurses

Session
Biomarker in liver disease: Risk and prediction

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)